Gilava Hamuni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gilava Hamuni has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Karabatsiakis
University of Innsbruck, Department of Psychology, Clinical Psychology II, Universitätsstrasse 15, 6020 Innsbruck, Tyrol, Austria
1 shared publication - Durairaj Renu
Strand Life Sciences Pvt. Ltd., Bangalore, India
1 shared publication - Iris-Tatjana Kolassa
Ulm University
1 shared publication - Maggie Schauer
University of Konstanz
1 shared publication - Sarah Wilker
Clinical Psychology and Psychotherapy, Bielefeld University, Bielefeld, Germany
1 shared publication - Stephan Kolassa
SAP Switzerland AG, Tägerwilen, Switzerland
1 shared publication
Latest Publications
- Open Access
- 8 February 2015
- Published by Springer Nature in Journal of Molecular Psychiatry
- Vol. 3 (1) , 2-11
Metabolite profiling in posttraumatic stress disorder
Traumatic stress does not only increase the risk for posttraumatic stress disorder (PTSD), but is also associated with adverse secondary physical health outcomes. Despite increasing efforts, we only begin to understand the underlying biomolecular processes. The hypothesis-free assessment of a wide range of metabolites (termed metabolite profiling) might contribute to the discovery of biological pathways underlying PTSD. Here, we present the results of the first metabolite profiling study in PTSD, which investigated peripheral blood serum samples of 20 PTSD patients and 18 controls. We performed liquid chromatography (LC) coupled to Quadrupole/Time-Of-Flight (QTOF) mass spectrometry. Two complementary statistical approaches were used to identify metabolites associated with PTSD status including univariate analyses and Partial Least Squares Discriminant Analysis (PLS-DA). Thirteen metabolites displayed significant changes in PTSD, including four glycerophospholipids, and one metabolite involved in endocannabinoid signaling. A biomarker panel of 19 metabolites classifies PTSD with 85% accuracy, while classification accuracy from the glycerophospholipid with the highest differentiating ability already reached 82%. This study illustrates the feasibility and utility of metabolite profiling for PTSD and suggests lipid-derived and endocannabinoid signaling as potential biological pathways involved in trauma-associated pathophysiology.
- 8 February 2015
- Published by Springer Nature in Journal of Molecular Psychiatry
- Vol. 3 (1) , 2-11
Open AccessMetabolite profiling in posttraumatic stress disorder
Traumatic stress does not only increase the risk for posttraumatic stress disorder (PTSD), but is also associated with adverse secondary physical health outcomes. Despite increasing efforts, we only begin to understand the underlying biomolecular processes. The hypothesis-free assessment of a wide range of metabolites (termed metabolite profiling) might contribute to the discovery of biological pathways underlying PTSD. Here, we present the results of the first metabolite profiling study in PTSD, which investigated peripheral blood serum samples of 20 PTSD patients and 18 controls. We performed liquid chromatography (LC) coupled to Quadrupole/Time-Of-Flight (QTOF) mass spectrometry. Two complementary statistical approaches were used to identify metabolites associated with PTSD status including univariate analyses and Partial Least Squares Discriminant Analysis (PLS-DA). Thirteen metabolites displayed significant changes in PTSD, including four glycerophospholipids, and one metabolite involved in endocannabinoid signaling. A biomarker panel of 19 metabolites classifies PTSD with 85% accuracy, while classification accuracy from the glycerophospholipid with the highest differentiating ability already reached 82%. This study illustrates the feasibility and utility of metabolite profiling for PTSD and suggests lipid-derived and endocannabinoid signaling as potential biological pathways involved in trauma-associated pathophysiology.